Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
Go back to Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026| (NASDAQ: VYGR) | Delayed: 3.09 +0.05 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $30.54 | |||
| Open | $3.01 | 52 Week Low | $8.12 | |||
| Day High | $3.11 | P/E | N/A | |||
| Day Low | $3.00 | EPS | $0.00 | |||
| Volume | 538,083 | |||||

